Literature DB >> 25567358

CORR Insights(®): survival, recurrence, and function after epiphyseal preservation and allograft reconstruction in osteosarcoma of the knee.

Nicola Fabbri1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25567358      PMCID： PMC4385334          DOI： 10.1007/s11999-014-4121-9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  17 in total

1.  Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.

Authors:  Gaetano Bacci; Alessandra Longhi; Marilena Cesari; Michela Versari; Franco Bertoni
Journal:  Cancer       Date:  2006-06-15       Impact factor: 6.860

2.  Survival, recurrence, and function after epiphyseal preservation and allograft reconstruction in osteosarcoma of the knee.

Authors:  Luis Aponte-Tinao; Miguel A Ayerza; D Luis Muscolo; Germán L Farfalli
Journal:  Clin Orthop Relat Res       Date:  2014-10-29       Impact factor: 4.176

3.  A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status.

Authors:  Christian Wittekind; Carolyn Compton; Phil Quirke; Iris Nagtegaal; Susanne Merkel; Paul Hermanek; Leslie H Sobin
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

Review 4.  New targets and approaches in osteosarcoma.

Authors:  Jonathan Gill; Manpreet K Ahluwalia; David Geller; Richard Gorlick
Journal:  Pharmacol Ther       Date:  2012-09-14       Impact factor: 12.310

5.  "Skip" metastases in osteosarcoma.

Authors:  W F Enneking; A Kagan
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

6.  Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma.

Authors:  P Picci; L Sangiorgi; B T Rougraff; J R Neff; R Casadei; M Campanacci
Journal:  J Clin Oncol       Date:  1994-12       Impact factor: 44.544

7.  A system of staging musculoskeletal neoplasms.

Authors:  W F Enneking
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

8.  Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions.

Authors:  Michelle S Bradbury; Evan Phillips; Pablo H Montero; Sarah M Cheal; Hilda Stambuk; Jeremy C Durack; Constantinos T Sofocleous; Richard J C Meester; Ulrich Wiesner; Snehal Patel
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

9.  Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

Authors:  P A Meyers; R Gorlick; G Heller; E Casper; J Lane; A G Huvos; J H Healey
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544

10.  18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma.

Authors:  Colleen M Costelloe; Homer A Macapinlac; John E Madewell; Nancy E Fitzgerald; Osama R Mawlawi; Eric M Rohren; A Kevin Raymond; Valerae O Lewis; Peter M Anderson; Roland L Bassett; Robyn K Harrell; Edith M Marom
Journal:  J Nucl Med       Date:  2009-03       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.